13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
ISSUER PROFILE · CIK 0001649989 · CUSIP 69012T305

Outlook Therapeutics, Inc.OTLK

16 13D/G filings 5 distinct filers 9 insider transactions (365d)

Post-Filing Returns · across 2 activist filings on this issuer

Median 30d
0.0%
avg 0.0%
Median 60d
-13.5%
avg -13.5%
Median 90d
0.0%
avg 0.0%
Median 180d
0.0%
avg 0.0%

Returns measured from each activist filing's date_of_event, split + dividend adjusted via Yahoo Finance.

Cross-Reference Snapshot

Activist filings
16
1 SCHEDULE 13G · 2 SCHEDULE 13D/A · 1 SCHEDULE · 12 SC
Distinct filers
5
multi-activist cluster
Insiders (365d)
9
7 buys · 0 sales
Latest short DTC
1.64
as of 2026-08-31

13D/G Filings Timeline · 16 total

FiledFormFilerStakeSharesIntent
2026-08-19 SCHEDULE 13G CVI Investments, Inc. view →
2026-08-14 SCHEDULE 13D/A GMS Ventures & Investments 16.40% 42,631,142 view →
2026-06-01 SCHEDULE 13D/A GMS Ventures & Investments 37,580,638 view →
2025-01-22 SCHEDULE GMS Ventures & Investments 38.60% 12,725,216 view →
2022-07-08 SC Tenshi Healthcare Pte. Ltd. view →
2022-02-01 SC BioLexis Pte Ltd. view →
2021-02-05 SC Syntone Ventures LLC view →
2021-02-02 SC BioLexis Pte Ltd. view →
2020-03-24 SC BioLexis Pte Ltd. view →
2020-02-27 SC BioLexis Pte Ltd. view →
2020-01-31 SC BioLexis Pte Ltd. view →
2019-12-30 SC BioLexis Pte Ltd. view →
2019-04-17 SC BioLexis Pte Ltd. view →
2019-02-05 SC BioLexis Pte Ltd. view →
2019-01-03 SC BioLexis Pte Ltd. view →
2018-01-05 SC SABBY MANAGEMENT, LLC view →

Form 4 Insider Transactions · last 365d

DateInsiderRoleTypeSharesPriceValue
2026-08-14 KENYON LAWRENCE A director, officer Buy 101,010
2026-08-14 KENYON LAWRENCE A director, officer Buy 101,010 $1.10 $111K
2026-08-12 Sukhtian Ghiath M. director, 10%+ Buy 2,525,252 $0.99 $2.50M
2026-08-12 Sukhtian Ghiath M. director, 10%+ Buy 2,525,252 $1.10 $2.78M
2026-05-28 Sukhtian Ghiath M. director, 10%+ Buy 8,539,709 $0.59 $5.00M
2026-05-28 Sukhtian Ghiath M. director, 10%+ H 3,458,571 $2.26 $7.82M
2026-05-28 Sukhtian Ghiath M. director, 10%+ Buy 3,458,571 $0.59 $2.02M
2026-05-28 Sukhtian Ghiath M. director, 10%+ H 8,571,428 $1.40 $12.00M
2026-05-28 Sukhtian Ghiath M. director, 10%+ Buy 8,571,428 $0.59 $5.02M

FINRA Short Interest History

SettlementShort InterestDays to Cover% Δ vs prior
2026-08-31 32,910,138 1.64 +65.4%
2026-08-14 19,899,576 1.00 -0.6%
2026-07-31 20,013,892 1.09 +78.0%
2026-07-15 11,240,969 1.24 -19.8%
2026-06-30 14,014,673 1.00 +3.2%
2026-06-15 13,576,714 1.00 -15.8%
2026-05-29 16,133,268 1.00 +77.5%
2026-05-15 9,088,387 2.19 +41.3%
2026-04-30 6,433,813 1.20 +37.3%
2026-04-15 4,686,225 1.02 +47.3%
2026-03-31 3,180,446 1.00 -0.0%
2026-03-13 3,181,601 3.05 -13.8%

Alert me when any activist files on Outlook Therapeutics, Inc.

Free. We email you when criteria match. One-click unsubscribe in every email.

Track every activist who touches this name.

Custom alerts · full feed · daily intelligence · API. From $49/mo.

See pricing →